All community pharmacist articles
-
PHE/DH/DWP guidelineUKHSA COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
Independent professional body guideline
PCDS atopic eczema guideline
An overview of the management of atopic eczema, covering taking a clinical history and step-wise management
-
NICE guideline
NICE CKS on infective conjunctivitis
A summary of guidance to assist community pharmacy teams with the diagnosis and management of infective conjunctivitis
-
SIGN guideline
SIGN osteoporosis guideline
A brief summary of SIGN's guideline on management of osteoporosis and prevention of fragility fractures, including risk factors and a treatment algorithm.
-
NICE guideline
NICE CKS on earwax
This updated Guidelines for Pharmacy summary covers the diagnosis, management, and referral of people with earwax impaction
-
NICE guideline
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
-
Independent professional body guideline
FSRH guidance on incorrect use of combined hormonal contraception
This Guidelines summary guides management for when a woman has made a mistake using combined oral contraceptive pills, combined vaginal ring, and combined transdermal patch
-
SIGN guideline
SIGN interventions to prevent caries in children
A summary of guidance for community pharmacy teams to provide recommendations on interventions to prevent caries in children
-
NICE guideline
NICE CKS on diarrhoea in adults
A summary of NICE guidance on assessing and treating diarrhoea in adults, with recommendations on assessment, dehydration, and referral
-
Independent professional body guideline
Self Care Forum headache and migraine fact sheet
A summary of recommendations for advising patients and the public on managing headache and migraine
-
NICE guideline
NICE secondary bacterial infection of common skin conditions
This Guidelines summary covers an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
PHE/DH/DWP guideline
PHE oral health in children guidance
A summary of guidance to assist community pharmacy teams to promote the benefits of good oral health for children
-
NICE guideline
NICE CKS on chickenpox
Management of chickenpox in healthy children and adults, during pregnancy and breastfeeding, and in people who are immunocompromised
-
NICE guideline
NICE CKS on common cold
A useful summary for community pharmacists covering diagnosis, management, and prescribing information in adults, children, and young people
-
NICE guideline
NICE CKS on halitosis
A summary of guidance to assist community pharmacy teams on the diagnosis and management of halitosis (bad breath)
-
NICE guideline
NICE CKS on gingivitis and periodontitis
A summary of guidance to assist community pharmacy teams on the diagnosis and management of gingivitis and periodontitis
-
Independent professional body guideline
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
-
NICE guideline
NICE CKS on rosacea
A summary of guidance to assist healthcare professionals on the diagnosis and management of rosacea
-
News
COVID-19 vaccinations to be delivered by high street pharmacies from today
As the NHS accelerates its largest vaccination programme to date, high street pharmacies have begun delivering protective COVID-19 vaccinations
